Clinical Trials Directory

Trials / Unknown

UnknownNCT05389254

Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome

Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetes Mellitus Patients With Acute Coronary Syndrome

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Ningbo No. 1 Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to use real-time continuous glucose monitoring (real-time CGM) system to get a 14-days blood glucose profile of the hospitalized type 2 diabetes mellitus (T2DM) patients with acute coronary syndrome (ACS), and to understand whether time in range (TIR) is associated with in-hospital outcomes of these patients. This study plans to recruit 100 patients. They will be randomly divided into 2 groups: real-time CGM group and capillary blood glucose monitoring group. All enrolled participants will receive standardized blood glucose management according to the "Expert consensus on blood glucose management of inpatients in China". The duration of the study will be 3 months. The primary endpoint is the average hospital stay and cardiac care unit (CCU) occupancy rate in T2DM patients with ACS. The secondary endpoint is a composite endpoint of nonfatal myocardial infarction, acute heart failure, heart failure rehospitalization, coronary revascularization, cardiovascular death, all-cause death.

Conditions

Interventions

TypeNameDescription
DEVICEcontinuous glucose monitoring systemuse real-time CGM system to check and adjust blood glucose
DEVICEcapillary blood glucose monitoringmonitor blood glucose with finger blood; real-time CGM is blind to both participants and researchers

Timeline

Start date
2022-06-01
Primary completion
2023-06-01
Completion
2023-12-01
First posted
2022-05-25
Last updated
2022-05-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05389254. Inclusion in this directory is not an endorsement.